Our Partnering Model
We have a history of successful partnerships with companies across markets
Our partnering model builds on
- an integrated business development and licensing (BD&L) approach, from target identification to project implementation
- broad market screening and scouting for new opportunities through dedicated teams
- state of the art deal-making, applying classical as well as innovative deal structuring
- professional deal implementation and cooperation through a dedicated Strategic Alliance Management function
As a worldwide leader in pain, we are currently strengthening our pain portfolio.
In parallel, we are expanding into pain-related indications as well as small or orphan indications.
In addition, we are exploring medical devices and technology platforms – for markets in Europe, Latin America and the U.S.
In 2016, we entered the hospital market in Europe with Zalviso®, a pre-programmed, non-invasive device for the management of acute post-operative pain, and we are looking for further opportunities in the hospital market.